AstraZeneca Pharma India Limited (ASTRAZEN.BO)
INR 8061.9
(2.24%)
INR 8061.9
(2.24%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 2.27 Billion INR | 19.81% |
| 2022 | 1.9 Billion INR | 35.65% |
| 2021 | 1.4 Billion INR | -12.25% |
| 2020 | 1.59 Billion INR | -3.24% |
| 2019 | 1.65 Billion INR | 39.84% |
| 2018 | 1.18 Billion INR | 4.37% |
| 2017 | 1.13 Billion INR | 96.07% |
| 2016 | 577.1 Million INR | -24.79% |
| 2015 | 767.3 Million INR | -10.91% |
| 2014 | 861.3 Million INR | -10.05% |
| 2013 | 957.57 Million INR | 12.17% |
| 2012 | 853.69 Million INR | 13.68% |
| 2011 | 750.96 Million INR | 31.28% |
| 2010 | 572.02 Million INR | 62.51% |
| 2009 | 352 Million INR | 3.51% |
| 2008 | 340.06 Million INR | 42.96% |
| 2007 | 237.87 Million INR | -27.91% |
| 2006 | 329.98 Million INR | 31.35% |
| 2005 | 251.22 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 FY | 2.27 Billion INR | 19.81% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 2.66 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q4 | 2.27 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 1.9 Billion INR | 35.65% |
| 2022 Q4 | 1.9 Billion INR | 0.0% |
| 2022 Q2 | 1.61 Billion INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 1.58 Billion INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 1.4 Billion INR | 0.0% |
| 2021 FY | 1.4 Billion INR | -12.25% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q2 | 1.94 Billion INR | 0.0% |
| 2020 Q4 | 1.59 Billion INR | 0.0% |
| 2020 FY | 1.59 Billion INR | -3.24% |
| 2019 FY | 1.65 Billion INR | 39.84% |
| 2019 Q2 | 1.25 Billion INR | 0.0% |
| 2019 Q4 | 1.65 Billion INR | 0.0% |
| 2018 Q4 | 1.18 Billion INR | 0.0% |
| 2018 Q2 | 788.64 Million INR | 0.0% |
| 2018 FY | 1.18 Billion INR | 4.37% |
| 2017 FY | 1.13 Billion INR | 96.07% |
| 2017 Q2 | 740.88 Million INR | 0.0% |
| 2017 Q4 | 1.13 Billion INR | 0.0% |
| 2016 Q2 | 700.95 Million INR | 0.0% |
| 2016 FY | 577.1 Million INR | -24.79% |
| 2016 Q4 | 577.1 Million INR | 0.0% |
| 2015 Q2 | 762.44 Million INR | 0.0% |
| 2015 FY | 767.3 Million INR | -10.91% |
| 2015 Q4 | 767.3 Million INR | 0.0% |
| 2014 Q2 | 959.05 Million INR | 0.0% |
| 2014 FY | 861.3 Million INR | -10.05% |
| 2014 Q4 | 861.3 Million INR | 0.0% |
| 2013 Q2 | 697.73 Million INR | 0.0% |
| 2013 FY | 957.57 Million INR | 12.17% |
| 2013 Q4 | 957.57 Million INR | 0.0% |
| 2012 Q4 | 853.69 Million INR | 0.0% |
| 2012 FY | 853.69 Million INR | 13.68% |
| 2011 Q4 | 750.96 Million INR | 0.0% |
| 2011 FY | 750.96 Million INR | 31.28% |
| 2010 FY | 572.02 Million INR | 62.51% |
| 2009 FY | 352 Million INR | 3.51% |
| 2008 FY | 340.06 Million INR | 42.96% |
| 2007 FY | 237.87 Million INR | -27.91% |
| 2006 FY | 329.98 Million INR | 31.35% |
| 2005 FY | 251.22 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 86.135% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 97.677% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 65.814% |
| Granules India Limited | 13 Billion INR | 82.478% |
| Indoco Remedies Limited | 3.53 Billion INR | 35.455% |
| Achyut Healthcare Limited | 568 Thousand INR | -401100.704% |
| Ajanta Pharma Limited | 8.28 Billion INR | 72.49% |
| Alkem Laboratories Limited | 26.61 Billion INR | 91.437% |
| Alpa Laboratories Limited | 136.65 Million INR | -1567.596% |
| Brooks Laboratories Limited | 96.1 Million INR | -2271.103% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -58.209% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -92.391% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 96.414% |
| Eris Lifesciences Limited | 1.89 Billion INR | -20.552% |
| FDC Limited | 3.88 Billion INR | 41.402% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 90.932% |
| Gufic Biosciences Limited | 2 Billion INR | -13.667% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -2079.083% |
| Ipca Laboratories Limited | 24.71 Billion INR | 90.779% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -1419.517% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -2226.181% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1096.646% |
| Laurus Labs Limited | 18.45 Billion INR | 87.651% |
| Lupin Limited | 49.53 Billion INR | 95.4% |
| Mankind Pharma Limited | 15.53 Billion INR | 85.331% |
| Medicamen Biotech Limited | 593.75 Million INR | -283.8% |
| Medico Remedies Limited | 163.37 Million INR | -1294.866% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 67.469% |
| Piramal Pharma Limited | 21.75 Billion INR | 89.527% |
| RPG Life Sciences Limited | 1.01 Billion INR | -125.626% |
| Sigachi Industries Limited | 707.2 Million INR | -222.228% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 97.691% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | 1.433% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -980.957% |
| Unichem Laboratories Limited | 7.04 Billion INR | 67.661% |
| Wanbury Limited | 360.23 Million INR | -532.598% |
| Windlas Biotech Limited | 621.89 Million INR | -266.435% |
| ZIM Laboratories Limited | 812.62 Million INR | -180.426% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 93.379% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 92.843% |
| Hester Biosciences Limited | 755.81 Million INR | -201.507% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -108.855% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -688.391% |
| Bal Pharma Limited | 878.11 Million INR | -159.513% |
| Strides Pharma Science Limited | 11.26 Billion INR | 79.766% |
| Venus Remedies Limited | 1.21 Billion INR | -87.264% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 64.552% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 67.866% |
| Shilpa Medicare Limited | 3.44 Billion INR | 33.933% |
| Aarti Drugs Limited | 4.85 Billion INR | 53.1% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 46.361% |
| Suven Life Sciences Limited | 7.08 Million INR | -32064.008% |
| Ind-Swift Limited | 640.91 Million INR | -255.557% |
| Valiant Laboratories Limited | 100.15 Million INR | -2175.316% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 54.651% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 36.647% |
| Themis Medicare Limited | 705.74 Million INR | -222.897% |
| Hikal Limited | 3.03 Billion INR | 24.97% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 90.001% |
| Sequent Scientific Limited | 3.46 Billion INR | 34.182% |
| Novartis India Limited | 448.6 Million INR | -407.985% |
| Wockhardt Limited | 6.4 Billion INR | 64.393% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 82.329% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -8837.601% |
| Neuland Laboratories Limited | 3.5 Billion INR | 34.969% |
| Morepen Laboratories Limited | 2.48 Billion INR | 8.332% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -5614.193% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -84.311% |